End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.54 CNY | -1.57% | -4.93% | -23.64% |
May. 20 | Hubei Goto Biopharm Co.,Ltd. Approves Cash Dividend for the Year 2023 | CI |
Apr. 26 | Hubei Goto Biopharm Co.,Ltd. Proposes Final Cash Dividend for 2023 | CI |
Sales 2022 | 605M 83.43M | Sales 2023 | 566M 78.16M | Capitalization | 2.65B 365M |
---|---|---|---|---|---|
Net income 2022 | 40M 5.52M | Net income 2023 | 23M 3.17M | EV / Sales 2022 | 5.67 x |
Net Debt 2022 | 317M 43.73M | Net Debt 2023 | 604M 83.31M | EV / Sales 2023 | 5.74 x |
P/E ratio 2022 |
77.5
x | P/E ratio 2023 |
115
x | Employees | 631 |
Yield 2022 * |
-
| Yield 2023 |
0.07% | Free-Float | 40.55% |
1 day | -1.57% | ||
1 week | -4.93% | ||
Current month | -6.35% | ||
1 month | -1.29% | ||
3 months | -11.01% | ||
6 months | -28.47% | ||
Current year | -23.64% |
Managers | Title | Age | Since |
---|---|---|---|
Zu Bin Xi
CEO | Chief Executive Officer | 53 | 06-05-14 |
Xiang Dong Liu
DFI | Director of Finance/CFO | 50 | 16-09-30 |
Ming Lei Li
BRD | Director/Board Member | 46 | 08-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Cai Xia
BRD | Director/Board Member | 74 | 18-10-15 |
Jian Yang
BRD | Director/Board Member | 54 | 18-10-15 |
Zu Bin Xi
CEO | Chief Executive Officer | 53 | 06-05-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 17.54 | -1.57% | 3 679 900 |
24-06-04 | 17.82 | -1.87% | 6,071,687 |
24-06-03 | 18.16 | -3.04% | 4,692,034 |
24-05-31 | 18.73 | -1.21% | 4,484,800 |
24-05-30 | 18.96 | +0.48% | 6,847,799 |
End-of-day quote Shenzhen S.E., June 04, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-23.64% | 284M | |
-0.28% | 90.59B | |
0.00% | 38.99B | |
-9.29% | 34.09B | |
+64.13% | 26.38B | |
-18.20% | 15.02B | |
-6.34% | 13.17B | |
-10.69% | 11.88B | |
-47.78% | 10.65B | |
+8.09% | 9.25B |
- Stock Market
- Equities
- 300966 Stock